Package 65219-801-01

Brand: glycopyrrolate

Generic: glycopyrrolate
NDC Package

Package Facts

Identity

Package NDC 65219-801-01
Digits Only 6521980101
Product NDC 65219-801
Product ID 65219-801_516b2ac1-7eab-4d63-a0d0-97245858a1d0
Description

25 VIAL, SINGLE-DOSE in 1 CARTON (65219-801-01) / 1 mL in 1 VIAL, SINGLE-DOSE (65219-801-00)

Marketing

Marketing Status
Marketed Since 2023-12-31
Brand glycopyrrolate
Generic glycopyrrolate
Sample Package No

Linked Drug Pages (1)

Glycopyrrolate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "516b2ac1-7eab-4d63-a0d0-97245858a1d0", "openfda": {"upc": ["0365219801009"], "unii": ["V92SO9WP2I"], "rxcui": ["1731582"], "spl_set_id": ["250eeef7-b1a9-45e7-a927-7807232e10be"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (65219-801-01)  / 1 mL in 1 VIAL, SINGLE-DOSE (65219-801-00)", "package_ndc": "65219-801-01", "marketing_start_date": "20231231"}], "brand_name": "Glycopyrrolate", "product_id": "65219-801_516b2ac1-7eab-4d63-a0d0-97245858a1d0", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]"], "product_ndc": "65219-801", "generic_name": "Glycopyrrolate", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Glycopyrrolate", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": ".2 mg/mL"}], "application_number": "ANDA209328", "marketing_category": "ANDA", "marketing_start_date": "20231231", "listing_expiration_date": "20261231"}